Danska - danski - Lægemiddelstyrelsen (Danish Medicines Agency)

eql pharma ab - prednisolon - tabletter - 5 mg

Danska - danski - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 aps - cannabis ekstrakt (cbd), cannabis ekstrakt (thc) - mundhulespray, opløsning - 27+25 mg/ml

Europska Unija - danski - EMA (European Medicines Agency)

accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastiske midler - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase.  chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib.  ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib.  newly diagnosed ph+ all in combination with chemotherapy.

Danska - danski - Lægemiddelstyrelsen (Danish Medicines Agency)

eql pharma ab - kaliumchlorid - depottabletter - 750 mg

Europska Unija - danski - EMA (European Medicines Agency)

merck sharp dohme ltd  - peginterferon alfa-2b - hepatitis c kronisk - immunostimulants, - adults (tritherapy)viraferonpeg in combination with ribavirin and boceprevir (tritherapy) is indicated for the treatment of chronic-hepatitis-c (chc) genotype-1 infection in adult patients (18 years of age and older) with compensated liver disease who are previously untreated or who have failed previous therapy. der henvises til ribavirin og boceprevir produktresuméer (smpcs), når viraferonpeg skal anvendes i kombination med disse lægemidler. adults (bitherapy and monotherapy)viraferonpeg is indicated for the treatment of adult patients (18 years of age and older) with chc who are positive for hepatitis-c-virus rna (hcv-rna), including patients with compensated cirrhosis and / or co-infected with clinically stable hiv. viraferonpeg i kombination med ribavirin (bitherapy) er indiceret til behandling af chc-infektion hos voksne patienter, der er tidligere ubehandlet, herunder patienter med klinisk stabilt hiv co-infektion, og hos voksne patienter, der har undladt tidligere behandling med interferon alfa (pegyleret eller non-pegyleret) og ribavirin kombination terapi eller interferon alfa-monoterapi. interferon monoterapi, herunder viraferonpeg, er indikeret primært i tilfælde af intolerance eller kontraindikation for ribavirin. der henvises til ribavirin spc, når viraferonpeg er at blive brugt i kombination med ribavirin. paediatric population (bitherapy)viraferonpeg is indicated in a combination regimen with ribavirin for the treatment of children three years of age and older and adolescents, who have chronic hepatitis c, previously untreated, without liver decompensation, and who are positive for hcv-rna. når det besluttes ikke at udsætte behandlingen, indtil voksenalderen, det er vigtigt at overveje, at kombinationen af terapi-induceret vækst-hæmning, der kan være uoprettelige hos nogle patienter. beslutningen om at behandle en sag-for-sag. der henvises til ribavirin produktresumeet for kapsler eller oral opløsning, når viraferonpeg er at blive brugt i kombination med ribavirin.

Danska - danski - Lægemiddelstyrelsen (Danish Medicines Agency)

europharma.dk aps - amoxicillintrihydrat - filmovertrukne tabletter - 1000 mg

Danska - danski - Lægemiddelstyrelsen (Danish Medicines Agency)

europharma.dk aps - amoxicillintrihydrat - filmovertrukne tabletter - 500 mg

Danska - danski - Lægemiddelstyrelsen (Danish Medicines Agency)

europharma.dk aps - amoxicillintrihydrat - filmovertrukne tabletter - 750 mg

Danska - danski - Lægemiddelstyrelsen (Danish Medicines Agency)

aaa-pharma gmbh - doxazosinmesilat - depottabletter - 4 mg

Danska - danski - Lægemiddelstyrelsen (Danish Medicines Agency)

alliance pharma (ireland) ltd - terlipressinacetat - pulver og solvens til injektionsvæske, opløsning - 1 mg